Published in Oncogene on December 21, 2009
TGF-β upregulates miR-181a expression to promote breast cancer metastasis. J Clin Invest (2012) 2.44
MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest (2012) 2.24
The tumor microenvironment in hepatocellular carcinoma: current status and therapeutic targets. Semin Cancer Biol (2010) 2.07
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. Drug Resist Updat (2010) 1.98
Transforming growth factor-β regulates the sphere-initiating stem cell-like feature in breast cancer through miRNA-181 and ATM. Oncogene (2010) 1.92
The inflammatory microenvironment in hepatocellular carcinoma: a pivotal role for tumor-associated macrophages. Biomed Res Int (2012) 1.53
The role of microRNAs in liver cancer progression. Br J Cancer (2010) 1.52
Functional analysis of microRNAs in human hepatocellular cancer stem cells. J Cell Mol Med (2012) 1.35
The role of microRNAs in human liver cancers. Semin Oncol (2011) 1.34
'See-saw' expression of microRNA-198 and FSTL1 from a single transcript in wound healing. Nature (2013) 1.31
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J Clin Invest (2012) 1.29
Altered MicroRNA processing in heritable pulmonary arterial hypertension: an important role for Smad-8. Am J Respir Crit Care Med (2011) 1.27
MiR-181d acts as a tumor suppressor in glioma by targeting K-ras and Bcl-2. J Cancer Res Clin Oncol (2011) 1.27
The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness. Biochim Biophys Acta (2012) 1.26
Anti-microRNA-222 (anti-miR-222) and -181B suppress growth of tamoxifen-resistant xenografts in mouse by targeting TIMP3 protein and modulating mitogenic signal. J Biol Chem (2011) 1.24
Oncogenic miR-181a/b affect the DNA damage response in aggressive breast cancer. Cell Cycle (2013) 1.23
Prevention of hepatocellular carcinoma: potential targets, experimental models, and clinical challenges. Curr Cancer Drug Targets (2012) 1.23
Hepatic stem cells and transforming growth factor β in hepatocellular carcinoma. Nat Rev Gastroenterol Hepatol (2012) 1.17
MiR-181 family: regulators of myeloid differentiation and acute myeloid leukemia as well as potential therapeutic targets. Oncogene (2014) 1.16
MicroRNAs in hepatocellular carcinoma: regulation, function, and clinical implications. ScientificWorldJournal (2013) 1.16
Identification of a New Pathway for Tumor Progression: MicroRNA-181b Up-Regulation and CBX7 Down-Regulation by HMGA1 Protein. Genes Cancer (2010) 1.13
Shielding the messenger (RNA): microRNA-based anticancer therapies. Pharmacol Ther (2011) 1.12
The genetic and epigenetic alterations in human hepatocellular carcinoma: a recent update. Protein Cell (2014) 1.10
Identification of circulating microRNAs as potential biomarkers for detecting acute myeloid leukemia. PLoS One (2013) 1.08
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? Cell Biosci (2011) 1.08
MetastamiRs: non-coding MicroRNAs driving cancer invasion and metastasis. Int J Mol Sci (2012) 1.04
Analysis of circulating microRNAs in adrenocortical tumors. Lab Invest (2013) 1.04
MicroRNAs, diet, and cancer: new mechanistic insights on the epigenetic actions of phytochemicals. Mol Carcinog (2011) 1.04
Novel hepatocellular carcinoma molecules with prognostic and therapeutic potentials. World J Gastroenterol (2014) 1.04
Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma (2013) 1.03
miR-224 functions as an onco-miRNA in hepatocellular carcinoma cells by activating AKT signaling. Oncol Lett (2012) 1.01
Endometrial miR-181a and miR-98 expression is altered during transition from normal into cancerous state and target PGR, PGRMC1, CYP19A1, DDX3X, and TIMP3. J Clin Endocrinol Metab (2012) 1.00
Reciprocal regulation of microRNA-122 and c-Myc in hepatocellular cancer: role of E2F1 and transcription factor dimerization partner 2. Hepatology (2013) 0.99
Prognostic role of microRNA-181a/b in hematological malignancies: a meta-analysis. PLoS One (2013) 0.99
miRNAs regulate expression and function of extracellular matrix molecules. Matrix Biol (2012) 0.98
Epigenetics of hepatocellular carcinoma: role of microRNA. World J Gastroenterol (2013) 0.95
miRNA signature and Dicer requirement during human endometrial stromal decidualization in vitro. PLoS One (2012) 0.95
MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells. Nat Struct Mol Biol (2013) 0.95
microRNA-181 promotes prostate cancer cell proliferation by regulating DAX-1 expression. Exp Ther Med (2014) 0.94
MicroRNAs in Cancer Biology and Therapy: Current Status and Perspectives. Genes Dis (2014) 0.94
Osteopontin enhances the expression and activity of MMP-2 via the SDF-1/CXCR4 axis in hepatocellular carcinoma cell lines. PLoS One (2011) 0.94
Unraveling 50-Year-Old Clues Linking Neurodegeneration and Cancer to Cycad Toxins: Are microRNAs Common Mediators? Front Genet (2012) 0.92
MiR-181b sensitizes glioma cells to teniposide by targeting MDM2. BMC Cancer (2014) 0.91
Cholinesterase-Targeting microRNAs Identified in silico Affect Specific Biological Processes. Front Mol Neurosci (2011) 0.90
Differential regulation of extracellular tissue inhibitor of metalloproteinases-3 levels by cell membrane-bound and shed low density lipoprotein receptor-related protein 1. J Biol Chem (2012) 0.90
Suppression of latent transforming growth factor (TGF)-beta1 restores growth inhibitory TGF-beta signaling through microRNAs. J Biol Chem (2011) 0.90
Roles and mechanisms of microRNAs in pancreatic cancer. World J Surg (2011) 0.90
PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia. Cancer Res (2015) 0.90
MicroRNAs dysregulation in hepatocellular carcinoma: Insights in genomic medicine. World J Hepatol (2015) 0.89
miR-181b as a key regulator of the oncogenic process and its clinical implications in cancer (Review). Biomed Rep (2013) 0.89
microRNA-122 regulates hypoxia-inducible factor-1 and vimentin in hepatocytes and correlates with fibrosis in diet-induced steatohepatitis. Liver Int (2014) 0.89
MicroRNAs in the Regulation of MMPs and Metastasis. Cancers (Basel) (2014) 0.88
MicroRNAs and liver cancer associated with iron overload: therapeutic targets unravelled. World J Gastroenterol (2013) 0.88
Enhanced hepatic delivery of siRNA and microRNA using oleic acid based lipid nanoparticle formulations. J Control Release (2013) 0.88
Cellular microRNA miR-181b inhibits replication of mink enteritis virus by repression of non-structural protein 1 translation. PLoS One (2013) 0.87
MicroRNA and signal transduction pathways in tumor radiation response. Cell Signal (2013) 0.87
Cancer stem cell theory in gastrointestinal malignancies: recent progress and upcoming challenges. J Gastroenterol (2011) 0.86
microRNA expression pattern modulates temozolomide response in GBM tumors with cancer stem cells. Cell Mol Neurobiol (2014) 0.86
Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors. Cancer Biol Ther (2013) 0.85
Non-coding RNAs as theranostics in human cancers. J Cell Biochem (2012) 0.85
Implications of biomarkers in human hepatocellular carcinoma pathogenesis and therapy. World J Gastroenterol (2014) 0.85
TIMP-3 expression associates with malignant behaviors and predicts favorable survival in HCC. PLoS One (2014) 0.85
Alternative mRNA fates identified in microRNA-associated transcriptome analysis. BMC Genomics (2012) 0.84
Progress risk assessment of oral premalignant lesions with saliva miRNA analysis. BMC Cancer (2013) 0.84
The microRNAs as potential biomarkers for predicting the onset of aflatoxin exposure in human beings: a review. Front Microbiol (2014) 0.84
MiR-525-3p enhances the migration and invasion of liver cancer cells by downregulating ZNF395. PLoS One (2014) 0.84
MicroRNAs, TGF-β signaling, and the inflammatory microenvironment in cancer. Tumour Biol (2015) 0.84
MicroRNAs in Liver Health and Disease. Curr Pathobiol Rep (2013) 0.83
Reduced susceptibility of DNA methyltransferase 1 hypomorphic (Dnmt1N/+) mice to hepatic steatosis upon feeding liquid alcohol diet. PLoS One (2012) 0.83
The Dual Role of TGFβ in Human Cancer: From Tumor Suppression to Cancer Metastasis. ISRN Mol Biol (2012) 0.83
microRNAs: tiny RNA molecules, huge driving forces to move the cell. Protein Cell (2010) 0.83
Fibrogenesis and Carcinogenesis in Nonalcoholic Steatohepatitis (NASH): Involvement of Matrix Metalloproteinases (MMPs) and Tissue Inhibitors of Metalloproteinase (TIMPs). Cancers (Basel) (2014) 0.83
Staged miRNA re-regulation patterns during reprogramming. Genome Biol (2013) 0.82
miR-1228 promotes the proliferation and metastasis of hepatoma cells through a p53 forward feedback loop. Br J Cancer (2014) 0.82
Polymorphisms and Plasma Levels of Tissue Inhibitor of Metalloproteinase-3: Impact on Genetic Susceptibility and Clinical Outcome of Oral Cancer. Medicine (Baltimore) (2015) 0.82
TGF-β Controls miR-181/ERK Regulatory Network during Retinal Axon Specification and Growth. PLoS One (2015) 0.82
Autoregulatory loop between TGF-β1/miR-411-5p/SPRY4 and MAPK pathway in rhabdomyosarcoma modulates proliferation and differentiation. Cell Death Dis (2015) 0.81
TGF-β Mediated Crosstalk Between Malignant Hepatocyte and Tumor Microenvironment in Hepatocellular Carcinoma. Cancer Growth Metastasis (2014) 0.81
Hepatic loss of miR-122 predisposes mice to hepatobiliary cyst and hepatocellular carcinoma upon diethylnitrosamine exposure. Am J Pathol (2013) 0.81
Genome-Wide MicroRNA and Gene Analysis of Mesenchymal Stem Cell Chondrogenesis Identifies an Essential Role and Multiple Targets for miR-140-5p. Stem Cells (2015) 0.81
Complex temporal changes in TGFβ oncogenic signaling drive thyroid carcinogenesis in a mouse model. Carcinogenesis (2013) 0.81
TIMP3 controls cell fate to confer hepatocellular carcinoma resistance. Oncogene (2014) 0.81
Sweating the small stuff: microRNAs and genetic changes define pancreatic cancer. Pancreas (2013) 0.81
Function and clinical potential of microRNAs in hepatocellular carcinoma. Oncol Lett (2015) 0.81
miR-181a promotes G1/S transition and cell proliferation in pediatric acute myeloid leukemia by targeting ATM. J Cancer Res Clin Oncol (2015) 0.80
Epigenetic control of phospholipase A2 receptor expression in mammary cancer cells. BMC Cancer (2015) 0.80
Development of MicroRNA Therapeutics for Hepatocellular Carcinoma. Diagnostics (Basel) (2013) 0.80
The role of microRNAs in hepatocarcinogenesis: current knowledge and future prospects. J Gastroenterol (2013) 0.79
Role of Noncoding RNAs as Biomarker and Therapeutic Targets for Liver Fibrosis. Gene Expr (2015) 0.79
Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog. Biochim Biophys Acta (2014) 0.79
MicroRNA-181a enhances the chemotherapeutic sensitivity of chronic myeloid leukemia to imatinib. Oncol Lett (2015) 0.79
TGF-β/Smad2/3 signaling directly regulates several miRNAs in mouse ES cells and early embryos. PLoS One (2013) 0.79
TIMPs: versatile extracellular regulators in cancer. Nat Rev Cancer (2016) 0.79
miR-181a/b control the assembly of visual circuitry by regulating retinal axon specification and growth. Dev Neurobiol (2015) 0.78
Serum miR-128-2 serves as a prognostic marker for patients with hepatocellular carcinoma. PLoS One (2015) 0.78
Role of BMSCs in liver regeneration and metastasis after hepatectomy. World J Gastroenterol (2014) 0.78
MicroRNA 181b regulates decorin production by dermal fibroblasts and may be a potential therapy for hypertrophic scar. PLoS One (2015) 0.78
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods (2001) 414.27
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Silencing of microRNAs in vivo with 'antagomirs'. Nature (2005) 32.56
Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology (2007) 26.78
Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77
Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol (2009) 19.99
TGFbeta in Cancer. Cell (2008) 17.44
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41
Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol (2009) 11.50
LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45
SMAD proteins control DROSHA-mediated microRNA maturation. Nature (2008) 9.67
Getting to the root of miRNA-mediated gene silencing. Cell (2008) 7.17
Expression profiling identifies microRNA signature in pancreatic cancer. Int J Cancer (2007) 6.57
MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol (2008) 5.21
MicroRNA-221/222 confers tamoxifen resistance in breast cancer by targeting p27Kip1. J Biol Chem (2008) 4.56
MicroRNA-155 is regulated by the transforming growth factor beta/Smad pathway and contributes to epithelial cell plasticity by targeting RhoA. Mol Cell Biol (2008) 4.45
MicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell death. Oncogene (2008) 4.11
Identification of microRNA-181 by genome-wide screening as a critical player in EpCAM-positive hepatic cancer stem cells. Hepatology (2009) 3.92
Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression. Hepatology (2008) 3.68
Molecular mechanisms of hepatocellular carcinoma. Hepatology (2008) 3.51
MiRNAs and cancer. Am J Pathol (2009) 3.42
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells. Brain Res (2008) 3.20
Methylation mediated silencing of MicroRNA-1 gene and its role in hepatocellular carcinogenesis. Cancer Res (2008) 3.16
Down-regulation of micro-RNA-1 (miR-1) in lung cancer. Suppression of tumorigenic property of lung cancer cells and their sensitization to doxorubicin-induced apoptosis by miR-1. J Biol Chem (2008) 3.00
Abnormal TNF activity in Timp3-/- mice leads to chronic hepatic inflammation and failure of liver regeneration. Nat Genet (2004) 2.96
MicroRNAs in disease and potential therapeutic applications. Mol Ther (2007) 2.73
Transforming growth factor-beta-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res (2008) 2.44
Role of microRNA-155 at early stages of hepatocarcinogenesis induced by choline-deficient and amino acid-defined diet in C57BL/6 mice. Hepatology (2009) 2.29
MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. Hepatology (2009) 2.23
Transforming growth factor-beta gene expression signature in mouse hepatocytes predicts clinical outcome in human cancer. Hepatology (2008) 2.04
Non-coding MicroRNAs hsa-let-7g and hsa-miR-181b are Associated with Chemoresponse to S-1 in Colon Cancer. Cancer Genomics Proteomics (2006) 1.94
Tissue inhibitor of metalloproteinase 3 deficiency causes hepatic steatosis and adipose tissue inflammation in mice. Gastroenterology (2008) 1.36
Genes or environment to determine alcoholic liver disease and non-alcoholic fatty liver disease. Liver Int (2006) 1.34
The role of microRNA and other non-coding RNA in the pathogenesis of chronic lymphocytic leukemia. Best Pract Res Clin Haematol (2007) 1.34
Molecular targeted therapy for hepatocellular carcinoma. J Gastroenterol (2009) 1.32
Development of hepatocellular adenomas and carcinomas associated with fibrosis in C57BL/6J male mice given a choline-deficient, L-amino acid-defined diet. Jpn J Cancer Res (2002) 1.20
The genome of black cottonwood, Populus trichocarpa (Torr. & Gray). Science (2006) 21.03
Requirement of interleukin 17 receptor signaling for lung CXC chemokine and granulocyte colony-stimulating factor expression, neutrophil recruitment, and host defense. J Exp Med (2001) 12.38
The Arabidopsis Information Resource (TAIR): a comprehensive database and web-based information retrieval, analysis, and visualization system for a model plant. Nucleic Acids Res (2001) 11.93
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrob Agents Chemother (2000) 8.54
The Genome Sequence DataBase: towards an integrated functional genomics resource. Nucleic Acids Res (1999) 6.20
SOX9 is a potent activator of the chondrocyte-specific enhancer of the pro alpha1(II) collagen gene. Mol Cell Biol (1997) 5.72
Fix and flap: the radical orthopaedic and plastic treatment of severe open fractures of the tibia. J Bone Joint Surg Br (2000) 4.30
Haploinsufficiency of Sox9 results in defective cartilage primordia and premature skeletal mineralization. Proc Natl Acad Sci U S A (2001) 4.13
Leptin enters the brain by a saturable system independent of insulin. Peptides (1996) 3.97
A dual thrombin receptor system for platelet activation. Nature (1998) 3.96
Y-Chromosome evidence for a northward migration of modern humans into Eastern Asia during the last Ice Age. Am J Hum Genet (1999) 3.60
IL-17 stimulates granulopoiesis in mice: use of an alternate, novel gene therapy-derived method for in vivo evaluation of cytokines. J Immunol (1998) 3.37
Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice. Genes Dev (1989) 3.29
Role of thrombin signalling in platelets in haemostasis and thrombosis. Nature (2001) 3.15
Tissue factor- and factor X-dependent activation of protease-activated receptor 2 by factor VIIa. Proc Natl Acad Sci U S A (2000) 3.01
Crystal structure of delta9 stearoyl-acyl carrier protein desaturase from castor seed and its relationship to other di-iron proteins. EMBO J (1996) 2.84
Requirement of endogenous stem cell factor and granulocyte-colony-stimulating factor for IL-17-mediated granulopoiesis. J Immunol (2000) 2.81
Dentinogenesis imperfecta 1 with or without progressive hearing loss is associated with distinct mutations in DSPP. Nat Genet (2001) 2.75
Genetic relationship of populations in China. Proc Natl Acad Sci U S A (1998) 2.65
Transcriptional mechanisms of chondrocyte differentiation. Matrix Biol (2000) 2.61
A role for thrombin receptor signaling in endothelial cells during embryonic development. Science (2001) 2.55
Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem (2000) 2.50
Inactivation of the protein phosphatase 2A regulatory subunit A results in morphological and transcriptional defects in Saccharomyces cerevisiae. Mol Cell Biol (1992) 2.33
Microsurgical replantation of the avulsed scalp: report of 20 cases. Plast Reconstr Surg (1996) 2.17
Beta-adrenergic blockade accelerates conversion of postoperative supraventricular tachyarrhythmias. Anesthesiology (1998) 2.17
Signal, noise power spectrum, and detective quantum efficiency of indirect-detection flat-panel imagers for diagnostic radiology. Med Phys (1998) 2.06
Empirical and theoretical investigation of the noise performance of indirect detection, active matrix flat-panel imagers (AMFPIs) for diagnostic radiology. Med Phys (1997) 2.04
A simple method of decreasing the morbidity of split-thickness skin graft donor sites. Br J Plast Surg (1999) 1.95
Femoral vein ligation increases bone mass in the hindlimb suspended rat. Bone (1999) 1.95
The 19S regulatory complex of the proteasome functions independently of proteolysis in nucleotide excision repair. Mol Cell (1999) 1.92
The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells. Nat Med (2000) 1.92
Coding sequence for the pT181 repC product: a plasmid-coded protein uniquely required for replication. Proc Natl Acad Sci U S A (1982) 1.89
Insight into hepatocellular carcinogenesis at transcriptome level by comparing gene expression profiles of hepatocellular carcinoma with those of corresponding noncancerous liver. Proc Natl Acad Sci U S A (2001) 1.84
Laminar comparison of somatosensory cortical plasticity. Science (1994) 1.76
Characterization of TEM-1 beta-lactamase mutants from positions 238 to 241 with increased catalytic efficiency for ceftazidime. J Biol Chem (1994) 1.72
Cloning and functional characterization of a sigma receptor from rat brain. J Neurochem (1998) 1.68
Cloning of an amino acid transporter with functional characteristics and tissue expression pattern identical to that of system A. J Biol Chem (2000) 1.66
Incorporating language phenotypes strengthens evidence of linkage to autism. Am J Med Genet (2001) 1.65
Selection and characterization of amino acid substitutions at residues 237-240 of TEM-1 beta-lactamase with altered substrate specificity for aztreonam and ceftazidime. J Biol Chem (1996) 1.63
Latent species C adenoviruses in human tonsil tissues. J Virol (2008) 1.63
Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Transfusion Safety Study Group. Am J Epidemiol (1997) 1.62
Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. Immunol Rev (2000) 1.61
Inhibition of HIV type 1 infectivity by constrained alpha-helical peptides: implications for the viral fusion mechanism. Proc Natl Acad Sci U S A (1997) 1.61
Cathepsin G activates protease-activated receptor-4 in human platelets. J Biol Chem (2000) 1.60
Identity of the organic cation transporter OCT3 as the extraneuronal monoamine transporter (uptake2) and evidence for the expression of the transporter in the brain. J Biol Chem (1998) 1.59
A secondary drug resistance mutation of TEM-1 beta-lactamase that suppresses misfolding and aggregation. Proc Natl Acad Sci U S A (2001) 1.58
Identification of cDNAs encoding two G protein-coupled receptors for lysosphingolipids. FEBS Lett (1997) 1.57
Expansion of CREB's DNA recognition specificity by Tax results from interaction with Ala-Ala-Arg at positions 282-284 near the conserved DNA-binding domain of CREB. Proc Natl Acad Sci U S A (1994) 1.57
Protein kinase activity of RNA polymerase I purified from a rat hepatoma: probable function of Mr 42,000 and 24,600 polypeptides. Proc Natl Acad Sci U S A (1981) 1.56
New variant of TEM-10 beta-lactamase gene produced by a clinical isolate of proteus mirabilis. Antimicrob Agents Chemother (1995) 1.53
African origin of modern humans in East Asia: a tale of 12,000 Y chromosomes. Science (2001) 1.51
Different responses of soluble whole nuclear RNA polymerase and soluble nucleolar RNA polymerase to divalent cations and to inhibition by alpha-amanitin. Biochem Biophys Res Commun (1970) 1.51
Regulation of gene expression at the beginning of mammalian development. J Biol Chem (1995) 1.49
Improved GFR estimation by combined creatinine and cystatin C measurements. Kidney Int (2007) 1.48
Transdermal photopolymerized adhesive for seroma prevention. Plast Reconstr Surg (1999) 1.47
Factors influencing human immunodeficiency virus type 1 transmission by blood transfusion. Transfusion Safety Study Group. J Infect Dis (1996) 1.46
Valacyclovir: a substrate for the intestinal and renal peptide transporters PEPT1 and PEPT2. Biochem Biophys Res Commun (1998) 1.43
Comparison of five selective media for identifying fecal carriage of vancomycin-resistant enterococci. J Clin Microbiol (1996) 1.43
Roles of nitric oxide synthases in platelet-activating factor-induced intestinal necrosis in rats. Crit Care Med (1999) 1.43
The thioredoxin and glutaredoxin systems are efficient electron donors to human plasma glutathione peroxidase. J Biol Chem (1994) 1.40
Human Na(+)-dependent vitamin C transporter 1 (hSVCT1): primary structure, functional characteristics and evidence for a non-functional splice variant. Biochim Biophys Acta (1999) 1.39
Cigarette advertising and onset of smoking in children: questionnaire survey. BMJ (1996) 1.38
Imaging vascular function for early stage clinical trials using dynamic contrast-enhanced magnetic resonance imaging. Eur Radiol (2012) 1.38
Cardiogenic shock with takotsubo-like cardiomyopathy in functional retroperitoneal paraganglioma. Herz (2014) 1.38
A heparin-sensitive nuclear protein kinase. Purification, properties, and increased activity in rat hepatoma relative to liver. J Biol Chem (1981) 1.37
Structure-function analysis of protease-activated receptor 4 tethered ligand peptides. Determinants of specificity and utility in assays of receptor function. J Biol Chem (2000) 1.37
The 19S complex of the proteasome regulates nucleotide excision repair in yeast. Genes Dev (2001) 1.36
Suppression of metallothionein gene expression in a rat hepatoma because of promoter-specific DNA methylation. J Biol Chem (2000) 1.36
Human placental Na+-dependent multivitamin transporter. Cloning, functional expression, gene structure, and chromosomal localization. J Biol Chem (1999) 1.35
Mammalian RNA polymerases. Prog Nucleic Acid Res Mol Biol (1973) 1.35
Incidence of anomalous origin of coronary artery in 1879 Chinese adults on dual-source CT angiography. Neth Heart J (2010) 1.35
Nephrectomy during operative management of retroperitoneal sarcoma. Ann Surg Oncol (1997) 1.35
Human placental sodium-dependent vitamin C transporter (SVCT2): molecular cloning and transport function. Biochem Biophys Res Commun (1999) 1.35
An alternative molecular mechanism of action of 5-fluorouracil, a potent anticancer drug. Biochem Pharmacol (1997) 1.34
stumps, a Drosophila gene required for fibroblast growth factor (FGF)-directed migrations of tracheal and mesodermal cells. Genetics (1999) 1.34
Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells. Oncogene (2009) 1.34
Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium. J Biol Chem (2000) 1.33
Antigenic and genetic divergence of rabies viruses from bat species indigenous to Canada. Virus Res (2001) 1.32
Specific action of alpha-amanitin on mammalian RNA polymerase protein. Nature (1970) 1.32
Molecular and functional characterization of the intestinal Na+-dependent multivitamin transporter. Arch Biochem Biophys (1999) 1.32
Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells. Invest Ophthalmol Vis Sci (2001) 1.31
Cloning of the human thiamine transporter, a member of the folate transporter family. J Biol Chem (1999) 1.31
Crystal structure of transaldolase B from Escherichia coli suggests a circular permutation of the alpha/beta barrel within the class I aldolase family. Structure (1996) 1.31
The mouse W/c-kit locus. Ciba Found Symp (1990) 1.30
Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. J Pharmacol Exp Ther (1999) 1.29
Crystal structure of a catalytic antibody with a serine protease active site. Science (1994) 1.29
Backwards bifurcations and catastrophe in simple models of fatal diseases. J Math Biol (1998) 1.29
Methionine requirements of male white Peking ducks from twenty-one to forty-nine days of age. Poult Sci (2006) 1.28
Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2. J Pharm Sci (2000) 1.28
Nitric oxide synthase/COX cross-talk: nitric oxide activates COX-1 but inhibits COX-2-derived prostaglandin production. J Immunol (2000) 1.28
Activation of purified hepatoma RNA polymerase I by homologous protein kinase NII. J Biol Chem (1981) 1.28
Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function. Biochem Biophys Res Commun (1999) 1.27
Cephalosporin substrate specificity determinants of TEM-1 beta-lactamase. J Biol Chem (1997) 1.25
Altered characteristics of mammalian RNA polymerase following solubilization from nuclei. Biochem Biophys Res Commun (1968) 1.25
Nutritional assessment with bioelectrical impedance analysis in maintenance hemodialysis patients. J Am Soc Nephrol (1995) 1.25
Na+- and Cl--coupled active transport of carnitine by the amino acid transporter ATB(0,+) from mouse colon expressed in HRPE cells and Xenopus oocytes. J Physiol (2001) 1.24
NMR solution structure of complement-like repeat CR3 from the low density lipoprotein receptor-related protein. Evidence for specific binding to the receptor binding domain of human alpha(2)-macroglobulin. J Biol Chem (2000) 1.24